He graduated as MD at Universidad de la Republica in Uruguay and his first area of research was orientated to the development of novel diagnostic method for E. granulosus infected dogs. In 2005, he moved to Ohio University, where his new area of research was focused on Wnt5a and its relationship with inflammation and cancer. In last 10 years, his research has been focused on two main goals, to analyze the role of Wnt5a signaling pathway in atherosclerosis, a chronic inflammatory disease; to understand the role of Wnt5a signaling in atherosclerosis to develop novel, safe, and cost-effective strategies for treatment; and, to dissect the expression pattern of Wnt5a in urothelial carcinoma, to find a novel molecular biomarker, as well as potential new targets for diagnosis and treatment to this cancer.